The global market for Eubiotics was estimated at US$7.3 Billion in 2024 and is projected to reach US$11.2 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Eubiotics market.
The demand for eubiotics has risen significantly as livestock farmers and feed manufacturers seek natural, sustainable solutions to enhance growth performance while ensuring food safety. Probiotics and prebiotics work synergistically to promote beneficial gut bacteria, reducing digestive disorders and improving nutrient absorption. Organic acids, such as fumaric and formic acid, help lower pH levels in the gut, inhibiting the growth of pathogenic bacteria. Meanwhile, essential oils derived from plants like oregano and thyme offer antimicrobial and anti-inflammatory benefits. As consumer awareness of food quality and sustainability grows, the adoption of eubiotics is expanding rapidly across poultry, swine, cattle, and aquaculture industries.
Another major shift in the industry is the increasing focus on precision nutrition and personalized eubiotic formulations. Researchers are leveraging genomics and microbiome analysis to develop customized eubiotic solutions tailored to specific livestock species, life stages, and environmental conditions. Additionally, the rising demand for organic and antibiotic-free meat products has encouraged the adoption of plant-based eubiotics, which offer natural antimicrobial properties without compromising animal growth rates. Regulatory frameworks are also playing a crucial role in shaping the market, with governments worldwide imposing stricter limits on antibiotic growth promoters (AGPs) and encouraging the use of natural alternatives like eubiotics. These trends are not only improving livestock health and productivity but also promoting sustainability and reducing the environmental impact of animal farming.
The swine sector is another key driver of eubiotic adoption, particularly in piglet diets where gut health plays a critical role in early growth and disease resistance. Prebiotics and essential oils are commonly added to swine feed to reduce post-weaning diarrhea, enhance immunity, and improve overall weight gain. Meanwhile, the ruminant industry, including cattle and dairy farming, is increasingly incorporating eubiotics to optimize rumen fermentation, improve milk yield, and reduce methane emissions. In aquaculture, probiotics and organic acids are being used to enhance fish and shrimp gut health, ensuring higher survival rates and better feed utilization. As global meat consumption rises and sustainability concerns grow, eubiotics are expected to play a greater role in shaping the future of livestock nutrition.
Advancements in microbiome research and feed formulation technologies have further expanded the application of eubiotics, enabling livestock producers to achieve better feed efficiency and lower production costs. The expansion of precision farming techniques, where real-time data on animal health and nutrition is used to optimize feed additives, is also driving the adoption of targeted eubiotic solutions. Furthermore, increasing investment in sustainable agriculture and climate-friendly livestock practices is promoting the use of eubiotics as a tool for reducing antibiotic dependency and improving overall animal welfare. With continued innovation, regulatory support, and rising consumer demand for natural and safe meat products, the eubiotics market is poised for significant growth, solidifying its role as a cornerstone of modern animal nutrition.
Global Eubiotics Market - Unveiling Key Trends & Growth Catalysts
Why Are Eubiotics Transforming Animal Nutrition and Gut Health?
Eubiotics have emerged as a critical component in modern animal nutrition, playing a pivotal role in improving gut health, enhancing immune response, and optimizing feed efficiency. These biologically active compounds include probiotics, prebiotics, organic acids, and essential oils, all of which contribute to maintaining a balanced microbiota in livestock and poultry. With growing concerns about antibiotic resistance and the push for antibiotic-free animal feed solutions, eubiotics are becoming an essential alternative for maintaining animal health and productivity.The demand for eubiotics has risen significantly as livestock farmers and feed manufacturers seek natural, sustainable solutions to enhance growth performance while ensuring food safety. Probiotics and prebiotics work synergistically to promote beneficial gut bacteria, reducing digestive disorders and improving nutrient absorption. Organic acids, such as fumaric and formic acid, help lower pH levels in the gut, inhibiting the growth of pathogenic bacteria. Meanwhile, essential oils derived from plants like oregano and thyme offer antimicrobial and anti-inflammatory benefits. As consumer awareness of food quality and sustainability grows, the adoption of eubiotics is expanding rapidly across poultry, swine, cattle, and aquaculture industries.
How Are Innovations and Sustainability Trends Reshaping the Eubiotics Market?
Technological advancements and sustainability trends are driving the evolution of the eubiotics market, leading to the development of more efficient and targeted gut health solutions. One of the most significant innovations is the introduction of microencapsulated eubiotics, which protect active ingredients from degradation and ensure controlled release in the digestive tract. This technology enhances the efficacy of probiotics, prebiotics, and essential oils, allowing for more consistent health benefits and improved feed conversion ratios in livestock.Another major shift in the industry is the increasing focus on precision nutrition and personalized eubiotic formulations. Researchers are leveraging genomics and microbiome analysis to develop customized eubiotic solutions tailored to specific livestock species, life stages, and environmental conditions. Additionally, the rising demand for organic and antibiotic-free meat products has encouraged the adoption of plant-based eubiotics, which offer natural antimicrobial properties without compromising animal growth rates. Regulatory frameworks are also playing a crucial role in shaping the market, with governments worldwide imposing stricter limits on antibiotic growth promoters (AGPs) and encouraging the use of natural alternatives like eubiotics. These trends are not only improving livestock health and productivity but also promoting sustainability and reducing the environmental impact of animal farming.
Which Livestock Sectors Are Driving the Expanding Eubiotics Market?
The poultry industry is one of the largest consumers of eubiotics, as maintaining optimal gut health is crucial for improving feed efficiency, egg production, and meat quality. Probiotics and organic acids are widely used in broiler and layer diets to prevent intestinal diseases such as necrotic enteritis and coccidiosis. With the rising demand for antibiotic-free chicken and organic poultry products, eubiotics are becoming an indispensable component in poultry feed formulations.The swine sector is another key driver of eubiotic adoption, particularly in piglet diets where gut health plays a critical role in early growth and disease resistance. Prebiotics and essential oils are commonly added to swine feed to reduce post-weaning diarrhea, enhance immunity, and improve overall weight gain. Meanwhile, the ruminant industry, including cattle and dairy farming, is increasingly incorporating eubiotics to optimize rumen fermentation, improve milk yield, and reduce methane emissions. In aquaculture, probiotics and organic acids are being used to enhance fish and shrimp gut health, ensuring higher survival rates and better feed utilization. As global meat consumption rises and sustainability concerns grow, eubiotics are expected to play a greater role in shaping the future of livestock nutrition.
What’s Fueling the Rapid Growth of the Eubiotics Market?
The growth in the global eubiotics market is driven by several factors, including the rising demand for antibiotic-free animal feed, increasing consumer awareness of food safety, and the push for sustainable livestock production. Stricter regulations banning the use of antibiotic growth promoters (AGPs) in animal feed, particularly in Europe and North America, have accelerated the shift toward natural gut health solutions such as probiotics, prebiotics, and organic acids. Additionally, the growing demand for high-quality animal protein, including poultry, pork, beef, and seafood, has fueled the need for feed additives that enhance productivity while minimizing disease outbreaks.Advancements in microbiome research and feed formulation technologies have further expanded the application of eubiotics, enabling livestock producers to achieve better feed efficiency and lower production costs. The expansion of precision farming techniques, where real-time data on animal health and nutrition is used to optimize feed additives, is also driving the adoption of targeted eubiotic solutions. Furthermore, increasing investment in sustainable agriculture and climate-friendly livestock practices is promoting the use of eubiotics as a tool for reducing antibiotic dependency and improving overall animal welfare. With continued innovation, regulatory support, and rising consumer demand for natural and safe meat products, the eubiotics market is poised for significant growth, solidifying its role as a cornerstone of modern animal nutrition.
SCOPE OF STUDY:
The report analyzes the Eubiotics market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Type (Probiotics, Organic Acids, Phytogenics, Prebiotics, Enzymes); Form (Solid, Liquid); Function (Nutrition & Gut Health, Immunity, Yield, Other Functions); End-Use (Poultry, Swine, Ruminants, Other End-Uses)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Probiotics segment, which is expected to reach US$4.0 Billion by 2030 with a CAGR of a 6.7%. The Organic Acids segment is also set to grow at 8.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $2.0 Billion in 2024, and China, forecasted to grow at an impressive 6.8% CAGR to reach $1.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Eubiotics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Eubiotics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Eubiotics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Bioproton Pty., Ltd., Calpis Co., Ltd., Cargill, Inc., Dostofarm GmbH, DSM-Firmenich AG and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 21 companies featured in this Eubiotics market report include:
- Bioproton Pty., Ltd.
- Calpis Co., Ltd.
- Cargill, Inc.
- Dostofarm GmbH
- DSM-Firmenich AG
- Koninklijke DSM N.V.
- MSPrebiotics, Inc.
- NATURE'S TRUTH UK
- Nuproxa Switzerland Ltd
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bioproton Pty., Ltd.
- Calpis Co., Ltd.
- Cargill, Inc.
- Dostofarm GmbH
- DSM-Firmenich AG
- Koninklijke DSM N.V.
- MSPrebiotics, Inc.
- NATURE’S TRUTH UK
- Nuproxa Switzerland Ltd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 184 |
Published | June 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 7.3 Billion |
Forecasted Market Value ( USD | $ 11.2 Billion |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Global |